Informatics: Opportunities & Applications. Professor Colin McCowan Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit

Similar documents
Hormone therapy and breast cancer: conflicting evidence. Cindy Farquhar Cochrane Menstrual Disorders and Subfertility Group

Big Data for Population Health

Individual Referencing Systems. Anthea Springbett Programme Principal SHIS-R NHS Information Services Division

Guideline for the Follow Up of Patients Following Treatment for Breast Cancer

Data platforms to support research, evaluation & practice. David V Ford Professor of Health Informatics School of Medicine, Swansea University

With Big Data Comes Big Responsibility

Digital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE

This vision does not represent government policy but provides useful insight into how breast cancer services might develop over the next 5 years

Big Data for health. Farr Institute, Administrative Data Research Centres, Medical Bioinformatics. 9 July Jacky Pallas, UCL

Key Health Areas Mapped to Out of Hospital Programme Areas

NHS outcomes framework and CCG outcomes indicators: Data availability table

THE AUSTRALIAN MESOTHELIOMA REGISTRY (AMR)

Analysis of Population Cancer Risk Factors in National Information System SVOD

Information Governance. A Clinician s Guide to Record Standards Part 1: Why standardise the structure and content of medical records?

Big Data for Population Health and Personalised Medicine through EMR Linkages

Randomized trials versus observational studies

Consultation Response Medical profiling and online medicine: the ethics of 'personalised' healthcare in a consumer age Nuffield Council on Bioethics

Swedish RWE a goldmine?

Likelihood of Cancer

The 100,000 genomes project

Improving survival and Clinical Trials Janyne Afseth Lecturer Edinburgh Napier University

Cancer research in the Midland Region the prostate and bowel cancer projects

Everolimus plus exemestane for second-line endocrine treatment of oestrogen receptor positive metastatic breast cancer

Measuring quality along care pathways

Executive Summary and Recommendations: National Audit of Learning Disabilities Feasibility Study

Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group

Transforming Care After Treatment and the Ayrshire Experience

PATIENT INFORMATION SHEET

No. prev. doc.: 8770/08 SAN 64 Subject: EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS COUNCIL MEETING ON 9 AND 10 JUNE 2008

Patient Information Leaflet: Part 1 select-d

National Horizon Scanning Centre. Vandetanib (Zactima) for advanced or metastatic non-small cell lung cancer. December 2007

CPRD Clinical Practice Research Datalink Scotland Meeting May 2012

Breast Cancer Care & Research

School of Public Health and Health Services Department of Prevention and Community Health

Secondary Uses of Data for Comparative Effectiveness Research

ECONOMIC COSTS OF PHYSICAL INACTIVITY

Arthritis Research UK Epidemiology Unit

Health Data Governance: Privacy, Monitoring and Research - Policy Brief

Cancer Treatment Planning: A Means to Deliver Quality, Patient-Centered Care

Does my project require review by a Research Ethics Committee?

CLINICAL RESEARCH NETWORK

Tjeerd van Staa Professor of Health eresearch Centre for Health Informatics, University of Manchester

HSCIC Statistical Publications

Vaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for registered healthcare practitioners

BIG DATA SCIENTIFIC AND COMMERCIAL APPLICATIONS (ITNPD4) LECTURE: DATA SCIENCE IN MEDICINE

Service Specification Template Department of Health, updated June 2015

Big data size isn t enough! Irene Petersen, PhD Primary Care & Population Health

Health Information. Technology and Cancer Information Management. Health Information Technology & Cancer Information Management 363

Whitehall II Data Collection Procedure Phases 11 and 12

Early mortality rate (EMR) in Acute Myeloid Leukemia (AML)

Taking Part in Research at University Hospitals Birmingham

Using 'Big Data' to Estimate Benefits and Harms of Healthcare Interventions

Six Degrees of Separation No More: Using Data Linkages to Improve the Quality of Cancer Registry and Study Data

Public Health Training Prospectus

Clinical Practice Guidance for the Assessment of Young Women aged with Abnormal Vaginal Bleeding

Big data and connected challenges in cardiovascular health

References. Tobacco-Free Schools

Recruiting now. Could you help by joining this study?

Evaluation of a Primary Care Dermatology Service: final report

Prevent what is preventable, cure what is curable, provide palliative care for patients in need, and monitor and manage for results.

What you should know about Data Quality. A guide for health and social care staff

How To Prepare A Meeting For A Health Care Conference

Jill Malcolm, Karen Moir

Big Data and Oncology Care Quality Improvement in the United States

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care

Transcription:

Informatics: Opportunities & Applications Professor Colin McCowan Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit

Routine Data "routine data" is data collected as byproducts of clinical care by the clinician and as an integral part of the process of care. Williams JG, BMJ 1995;310;665-666 Secondary data : collected by someone else then used by researcher

From birth to death

Why use routine data? Already collected in many different healthcare and administrative settings Collection process not intrusive to target population Retrospective data available which is regularly updated Studies can be done now Costs of using data lower than for prospective collection Potential for datasets to be linked giving rich source of information about large numbers of patients with different conditions across diverse geographical and healthcare settings Collected in a consistent way Ethical and consent issues can be less problematic

Epidemiology Identify patients with specific disease or taking a specific treatment Use hospitalisations and death data to build-up clinical histories and investigate outcomes Support clinical trials Support feasibility studies and patient recruitment Passive follow-up of subjects : cheaper, maximises follow-up Support other research methods Cross-sectoral linkage Act as sampling frame for qualitative studies Research Using Routinely Collected Data

Women with breast cancer using endocrine therapy were missing tablets Study: Linking prescribing records to hospital discharge, cancer registry, cancer clinic data and mortality records Results: Low adherence was associated with poorer survival (HR=1.20; 95% CI=1.03 1.40, P=0.019) Adherence to medication in women with breast cancer

WOSCOPS follow-up % Landmark trial of statin use in patients with no previous CHD Study: Use record linkage of trial data to hospital discharge, cancer registry, and mortality records Results: 0 5 10 15 20 25 30 Placebo Pravastatin 0 2 4 6 8 10 12 14 16 Years since randomisation CHD death or CHD event

Cancer Screening in Women in Glasgow Lower uptake of bowel screening in women than for breast or cervical screening Study: Link screening records and examine difference in characteristics for uptake. Invite women for interview to explain why they use other cancer screening services but not bowel National Awareness and Early Diagnosis Initiative (NAEDI)

Scottish Health Informatics Programme

Creating safe settings and data security SHIP Blueprint highlights: Safe Projects Safe People Safe Data Safe Settings Safe Outputs

Safe Settings Thomas and Walport Data Sharing Review (2008): environments for population based research and statistical analysis in which the risk of identifying individuals is minimised

Safe Settings

Scottish Developments Farr Institute links centres from London, Manchester, Scotland and Swansea Scotland has 6 Universities plus NSS in partnership Core components Physical centres Safe havens e-infrastructure New data access Communication

Electronic Data Research and Innovation Service (edris) Glasgow Safe Haven Lothian Safe Haven

Predicting methotrexate response and toxicity using an integrated polyomic approach (PROMISE-RA) Study: Link clinical data from prescribing records and outpatient visits (SERA) to genetic data from sequenced samples Stratified Medicine Scotland - Innovation Centre

NHS Scotland funded programme to harness existing health data to support clinicians in improving patient outcomes and reduce harm from community and healthcare acquired infection Infection Intelligence platform Study: Link national Datasets pertinent to the comprehensive analysis of patterns in infection treatment, prevention, surveillance and clinical outcome